期刊文献+

高原环境对醋甲唑胺在大鼠体内药代动力学的影响 被引量:3

Pharmacokinetics of Methazolamide in Rats at High Altitude
下载PDF
导出
摘要 目的高原环境下醋甲唑胺在大鼠体内药代动力学特征研究。方法 Wistar大鼠于平原地区(~50 m)禁食12 h后将0.0049 g(约含醋甲唑胺0.476 mg)醋甲唑胺片剂灌胃给药,1周清洗期后急进高原(~4100 m),灌胃给药。平原组及急进高原组于给药前及给药后0.083、0.25、0.5、0.75、1、1.5、2、4、6、8、12、24 h由眼眶后静脉丛取血,采用LC-MS/MS方法测定血药浓度。结果醋甲唑胺急进高原组与平原组相比部分药代动力学参数发生显著变化,与高原组相比半衰期从(6.72±0.41)h减小到(2.61±0.72)h,体内平均驻留时间缩短,峰浓度增大。结论急进高原后,醋甲唑胺在大鼠体内的代谢发生显著变化,本研究结果为平原和急进高原后临床合理应用醋甲唑胺提供参考依据。 Objective To investigate the pharmacokinetics of methazolamide in rats after acute exposure to high altitude.Methods Methazolamide tablets of 0.0049 g were intragastrically administered to rats in low altitude(~50 m) and exposure to high altitude(~4100 m) groups.Blood samples were collected from veins of eye sockets into heparinized centrifuge tubes at 0,0.083,0.25,0.5,0.75,1,1.5,2,4,6,8,12 and 24 h after administration.Plasma concentration of methazolamide was determined by LC-MS/MS.Results Pharmacokinetic parameters of methazolamide at low altitude were significantly different from those of acute exposure to high altitude.Comparison of the t1/2 obtained in plasma in the two groups found a decrease from(6.725±0.406) to(2.61±0.715) h after acute exposure to high altitude.The MRT was lower than in the low-altitude group.Cmax was significantly higher in the acute-exposure-to-high-altitude group than in the low altitude group.Conclusion This study has found significant changes in the metabolism of methazolamide in rats after acute exposure to high altitude,which could be of therapeutic importance.This finding may provide some references for clinical rational use of methazolamide at low altitude and after acute exposure to high altitude.
出处 《解放军药学学报》 CAS 2013年第4期318-320,327,共4页 Pharmaceutical Journal of Chinese People's Liberation Army
基金 国家科技部重大资助项目 No.2008ZXJ09014-010 全军医药科研"十二五"重点项目 No.BWS12J012 全军医药科研"十二五"面上项目 No.CWS11C231
关键词 醋甲唑胺 急进高原 药代动力学 LC-MS MS methazolamide acute exposure to high altitude pharmacokinetics LC-MS/MS
  • 相关文献

参考文献6

  • 1孙芳云.从环境及遗传因素对药物生物转化的影响浅谈青藏高原开展临床药理学工作的重要性及用药注意事项[J].西藏医药,2000,21(1):34-36. 被引量:5
  • 2Li XY,Gao F,Li ZQ,et al.Comparison of the pharmacokinetics ofsulfamethoxazole in male chinese volunteers at low altitude and a-cute exposure to high altitude versus subjects living chronically athigh altitude:an open-label,controlled,prospective study[J].Clin-ical Therapeutics,2009,31(11):2744-2754.
  • 3Arancibia A,Nella GM,Paulos C,et al.Effects of high altitudeexposure on the pharmacokinetics of furosemide in healthy volun-teers[J].Int J Clin Pharm Ther,2004,42(6):314-320.
  • 4Streit M,Goggelmann C,Dehnert C,et al.Cytochrome p450 enzyme-mediated drug metabolism at exposure to acute hypoxia(correspondingto an ailtitude of 4,500 m)[J].Eur J Clin Pharmacol,2005,61(I):39-46.
  • 5陈新谦,金有豫,汤光.新编药物学[M].北京:人民卫生出版社,2011:609-621.
  • 6Wright AD,Winterbom MH,Forster PJ,et al.Carbonic anhydraseinhibition in the immediate therapy of acute mountain sickness[J].J Wilderness Medicine,1994,5(1):49-55.

二级参考文献5

共引文献184

同被引文献24

  • 1刘克辛,韩国柱.临床药物代谢动力学[M].北京:科学出版社,2009:57-79.
  • 2陈新谦,金有豫,汤光.新编药物学[M].北京:人民卫生出版社,2011:609-621.
  • 3张雪峰,等.人到高原[M].西宁:青海人民出版社,2001:2-6.
  • 4Gottlieb ~, Khatta M,Wentworth D, et al. The effeets of diu resis on the pharmaeokineties of the loop diuretics furosemide and bumetanide in patients with heart failure[J]. Am J Med, 1998,104:533-538.
  • 5Bianco S, Vaghi A, Pieroni MG, et al. Potentiation of the anti- reactive, antiasthmatie effect of inhaled furosemide by inhaled lysine aeetylsalieylate [J].Allergy, 1993,48 ~ 570-575.
  • 6Wright AD,Winterborn MH, Forster PJ,et al. Carbonic anhy drase inhibition in the immediate therapy of acute mountain sickness[J]. J Wild Med, 1994,5 ( 1 ) : 49 55.
  • 7Li XY,Gao F, Li ZQ, et al. Comparison of the pharmacokinet- its of sulfamethoxazole in male chinese volunteers at low alti- tude and acute exposure to high altitude versus subjects living chronically at high altitude: an open-label, controlled, prospec tive study[J]. Clin Therap, 2009,31 ( 11 ): 2744-2754.
  • 8张钢,周思敏,高钰琪,等.醋甲唑胺在制备治疗高原抗疲劳药物中的应用[P].专利号:CN201010291132.6.
  • 9张娟红,王荣,谢华,等.高原环境对B受体阻断剂药代动力学影响的研究[c].2013年中国药学大会暨第十三届中国药师周论文集,2013年.
  • 10陈春晖,王强,王志峰,唐水珍,梁杰珍,梁志锋,林军.乙酰唑胺对小鼠缺氧耐受的影响和机制研究[J].广西医科大学学报,2007,24(6):880-881. 被引量:2

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部